Anticholinergic burden visiting card references

1. Nishtala PS, Narayan SW, Wang T, et al. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf 2014;23:753-8.

2. Dmochowski RR, Thai S, Iglay K, et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn 2021;40:28-37. 

3. Veterans'MATES. Therapeutic Brief Topic 39: Thinking clearly about the anticholinergic burden - managing side effects. Canberra: Australian Government, 2014. (accessed 8 July 2021).

4. Australian Medicines Handbook. Adelaide: AMH Pty Ltd, 2021. (accessed 8 July 2021).

5. Therapeutic Guidelines. West Melbourne: Therapeutic Guidelines Ltd, 2021. (accessed 23 July 2021).

6. The University of Sydney. The goal-directed medication review electronic decision support system G-MEDSS. Sydney: USYD, 2019. (accessed 23 July 2021).

7. Parkinson L, Magin PJ, Thomson A, et al. Anticholinergic burden in older women: not seeing the wood for the trees? Med J Aust 2015;202:91-4. 

8. Veterans'MATES. Medicines: the hidden contributor to falls and hip fractures. Canberra: Australian Government, 2018. (accessed 6 August 2021).

9. Institute for Healthcare Improvement. Age-friendly health systems: Guide to using the 4Ms in the care of older adults. USA: IHI, 2020. (accessed 21 July 2021).

10. Mate K, Fulmer T, Pelton L, et al. Evidence for the 4Ms: interactions and outcomes across the care continuum. J Aging Health 2021;33:469-81. 

11. Cacchione PZ. Age-friendly health systems: The 4Ms Framework. Clin Nurs Res 2020;29:139-40. 

12. Verdoorn S, Kwint HF, Blom JW, et al. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: a randomised controlled trial (DREAMeR-study). PLoS Med 2019;16:e1002798.

13. Australian Commission on Safety and Quality in Health Care. Implementing the comprehensive care standard: identifying goals of care. Sydney: Australian Commission on Safety and Quality in Health Care, 2019.  (accessed 23 August 2021).

14. Australian Government Department of Health. Medication management reviews. Canberra: Australian Government Department of Health, 2014. (accessed 18 August 2021).

15. Department of Health. Medicare Benefits Schedule - Item 900. Canberra: Australian Government, 2021. (accessed 23 August 2021).

16. Department of Health. Medicare Benefits Schedule - Item 903. Canberra: Australian Government, 2021. (accessed 23 August 2021).

17. Department of Health. Combined review of fifth community pharmacy agreement medication management programmes: Final report. Canberra: Australian Government, 2015.(accessed 8 July 2021).

18. Stafford A, Tenni P, Peterson G, et al. IIG-021 - VALMER (the economic value of home medicines reviews): Final report. Canberra: The Pharmacy Guild of Australia, 2010. (accessed 24 August 2021).

19. Campbell Research & Consulting. Evaluation of the residential medication management review program: main findings report. Victoria: CR&C, 2010.  (accessed 24 August 2021).

20. Urbis Keys Young. Evaluation of the home medicines review program - pharmacy component. Melbourne: Urbis Keys Young, 2005. (accessed 24 August 2021).

21. Hava C. Understanding the barriers to RMMRs. Canberra: Australian Pharmacist, 2021. (accessed 8 July 2021).

22. Veterans'MATES. Not sure of the Home Medicines Review process? Canberra: Australian Government, 2016. (accessed 8 July 2021).

23. Weir KR, Naganathan V, Bonner C, et al. Pharmacists' and older adults' perspectives on the benefits and barriers of Home Medicines Reviews - a qualitative study. J Health Serv Res Policy 2020;25:77-85. 

24. Australian Government Department of Health. Sample DMMR referral form. Canberra: Australian Government Department of Health, 2014. (accessed 8 July 2021).

25. Pharmaceutical Society of Australia. Guidelines for comprehensive medication management reviews. Canberra: PSA, 2020. (accessed 13 July 2021).

26. Department of Health. Program rules: home medicines review. Canberra: Australian Government, 2021. (accessed 13 July 2021).

27. Veterans'MATES. Therapeutic Brief 29: Home Medicines Review - the benefits for you and your patients. Canberra: Australian Government, 2011. (accessed 8 July 2021).

1. Veterans'MATES. Medicines: the hidden contributor to falls and hip fractures. Canberra: Australian Government, 2018. (accessed 6 August 2021).

2. Therapeutic Guidelines. West Melbourne: Therapeutic Guidelines Ltd, 2021. (accessed 23 July 2021).

3. Kouladjian O'Donnell L, Gnjidic D, Nahas R, et al. Anticholinergic burden: considerations for older adults. J Pharm Pract Res 2017;47:67-77

4. Australian Medicines Handbook. Adelaide: AMH Pty Ltd, 2021. (accessed 8 July 2021).

5. The University of Sydney. The goal-directed medication review electronic decision support system G-MEDSS. Sydney: USYD, 2019. (accessed 23 July 2021).

6. Busse JW, Craigie S, Juurlink DN, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ 2017;189:E659-E66.

7. NPS MedicineWise. If not opioids, then what? Sydney: NPS MedicineWise, 2019. (accessed 6 August 2021).

8. NSW Therapeutic Advisory Group. Deprescribing guide for regular long-term opioid analgesic use (>3 months) in older adults. Sydney: NSW TAG Inc., 2018. (accessed 8 July 2021).

9. NSW Therapeutic Advisory Group. Deprescribing guide for sedating antihistamines. Sydney: NSW TAG Inc., 2018. (accessed 8 July 2021).